Cover Image

Cerebrovascular reactivity to hypercapnia in patients with migraine: A dual‐echo arterial spin labeling MRI study

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	E. S. Hoogeveen, N. Pelzer, E. Ghariq, M. J. P. van Osch, A. Dahan, G. M. Terwindt, M. C. Kruit
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Headache: The Journal of Head and Face Pain
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Substance use in a Dutch migraine cohort compared with the general population
by: Thomas C. van den Hoek, et al.
Published: (2024)

Useful considerations for treating migraine in patients with autism
by: Sinifunanya E. Nwaobi
Published: (2026)

A retrospective review of sex differences of white matter hyperintensities in brain MRI of patients with migraine
by: Ye Su, et al.
Published: (2024)

Advancing toward precision migraine treatment: Predicting responses to preventive medications with machine learning models based on patient and migraine features
by: Chia‐Chun Chiang, et al.
Published: (2024)

Evaluating dual calcitonin gene‐related peptide antagonists for chronic migraine prevention
by: Kara S. Graves, et al.
Published: (2026)

Cardiovascular risk and triptan usage among patients with migraine
by: Ido Peles, et al.
Published: (2025)

Reasons for patient reluctance to take preventive medications for migraine: Results of the OVERCOME ( US ) study
by: Jessica Ailani, et al.
Published: (2026)

Beyond symptom: Exploring the analgesic properties of vomiting in patients with migraine
by: Antonio Munafò, et al.
Published: (2026)

A 52‐week open‐label extension study to evaluate the safety and efficacy of oral rimegepant for the preventive treatment of migraine
by: David Kudrow, et al.
Published: (2025)

Synergistic effect of combining dual enkephalinase inhibitor PL37 and sumatriptan in a preclinical model of migraine
by: Jeanne Rossignol, et al.
Published: (2024)

Unmet treatment needs in migraine: Results of the OVERCOME (US) study
by: Susan Hutchinson, et al.
Published: (2026)

Genetic migraine disorders and the response to calcitonin gene‐related peptide antagonist treatment
by: Andrea M. Kuczynski, et al.
Published: (2025)

Mapping the migraine: Intracranial recording of cortical spreading depression in migraine with aura
by: Graham A. McLeod, et al.
Published: (2025)

Genetically proxied liability to migraine and risk of intracranial aneurysm and subarachnoid hemorrhage
by: Iyas Daghlas, et al.
Published: (2024)

Flexible modeling of headache frequency fluctuations in migraine with hidden Markov models
by: Gina M. Dumkrieger, et al.
Published: (2024)

Heavy metal and trace element alterations in patients during a migraine attack
by: Sevilay Vural, et al.
Published: (2024)

Navigating the patient journey in migraine prevention: An American Migraine Foundation position paper
by: Lawrence C. Newman, et al.
Published: (2025)

A phase 1, multicenter, open‐label study to evaluate the pharmacokinetics, safety, and tolerability of a single dose of rimegepant in children (aged ≥6 to <12 years) with a history of migraine
by: Chay Ngee Lim, et al.
Published: (2025)

Novel optimization of multi‐mechanistic approaches for the acute treatment of a migraine attack: A review
by: Stephen Silberstein, et al.
Published: (2026)

Memantine as a migraine prophylactic agent in adolescents: A retrospective analysis
by: M. Ismail K. Yousaf, et al.
Published: (2025)

Heightened migraine risk in patients with rheumatoid arthritis: A national retrospective cohort study
by: Seonyoung Kang, et al.
Published: (2024)

Long‐term effectiveness of eptinezumab in the treatment of patients with chronic migraine and medication‐overuse headache
by: Andrew Blumenfeld, et al.
Published: (2024)

Impact of perilesional edema on severity of migraine in patients with calcified neurocysticercosis: A prospective evaluation
by: Vishwesh Vishnu Naik, et al.
Published: (2025)

Plain Language Summary Publication: Hyperactivity of the medial thalamus in patients with photophobia‐associated migraine
by: Yukihisa Suzuki, et al.
Published: (2024)

Study participant impression of use and satisfaction with STS101 (dihydroergotamine nasal powder): Results from the open‐label ASCEND acute migraine study
by: Jessica Ailani, et al.
Published: (2025)

The impacts of migraine on functioning: Results from two qualitative studies of people living with migraine
by: Rikki Mangrum, et al.
Published: (2024)

The effect of different exercise types on migraine frequency in individuals with migraine: A pilot study
by: Yunus Emre Meydanal, et al.
Published: (2025)

Prevalence and burden of migraine in the United States: A systematic review
by: Fred Cohen, et al.
Published: (2024)

Anxiety and depressive symptoms and migraine‐related outcomes in children and adolescents
by: Bilal Ahmed Rizvi, et al.
Published: (2024)

Do patients with migraine and obesity receive different treatments? Insights from real‐world data
by: Keshet Pardo, et al.
Published: (2025)

Characterizing the patient experience during the prodrome phase of migraine: A qualitative study of symptoms and their timing
by: Richard B. Lipton, et al.
Published: (2025)

Effects of fremanezumab on migraine‐associated symptoms and medication use in Japanese and Korean patients with episodic migraine: Exploratory endpoint analysis of a multicenter, randomized, double‐blind, placebo‐controlled trial
by: Muneto Tatsumoto, et al.
Published: (2024)

Waning light, waxing pain: The lunar cycle's association with migraine headache occurrence
by: Alexander Yoo, et al.
Published: (2025)

Glial activation in pain and emotional processing regions in the nitroglycerin mouse model of chronic migraine
by: Haley C. Cropper, et al.
Published: (2024)

Comparative bioavailability of single‐dose zavegepant during and between migraine attacks: A phase 1, randomized, open‐label, fixed‐sequence, two‐period study
by: Richard J. Bertz, et al.
Published: (2024)

Higher artificial intelligence‐ ECG atrial fibrillation prediction model output and estimated physiologic aging predict higher risk of adverse vascular events in patients with migraine
by: Ping‐Hao Yang, et al.
Published: (2026)

Evaluating associations of migraine‐related vertigo
by: Nazia Karsan, et al.
Published: (2025)

Effectiveness and tolerability of galcanezumab for migraine prevention in patients ≥65 years: A real‐life multicenter study
by: Julia Peris‐Subiza, et al.
Published: (2025)

Persistence, effectiveness, and tolerability of anti‐calcitonin gene–related peptide monoclonal antibodies in patients with chronic migraine
by: Anna de Dios, et al.
Published: (2024)

Headache‐related disability as a function of migraine aura: A daily diary study
by: Delora E. Denney, et al.
Published: (2024)